Steven R. Schow

1.2k total citations
41 papers, 918 citations indexed

About

Steven R. Schow is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Steven R. Schow has authored 41 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Organic Chemistry and 5 papers in Infectious Diseases. Recurrent topics in Steven R. Schow's work include Carbohydrate Chemistry and Synthesis (8 papers), HIV/AIDS drug development and treatment (5 papers) and Click Chemistry and Applications (5 papers). Steven R. Schow is often cited by papers focused on Carbohydrate Chemistry and Synthesis (8 papers), HIV/AIDS drug development and treatment (5 papers) and Click Chemistry and Applications (5 papers). Steven R. Schow collaborates with scholars based in United States and China. Steven R. Schow's co-authors include Trevor C. McMorris, Alison Joly, Michael M. Wick, Amos B. Smith, Robert T. Lum, Kevin N. Winzenberg, S.S. Kerwar, Andrew S. Thompson, Jonathan D. Bloom and Dov Shiffman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Steven R. Schow

39 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven R. Schow United States 17 439 390 146 78 72 41 918
Randall W. Hungate United States 22 643 1.5× 748 1.9× 141 1.0× 120 1.5× 49 0.7× 51 1.4k
Gool F. Patel United States 9 476 1.1× 215 0.6× 110 0.8× 62 0.8× 68 0.9× 11 877
Stephan K. Grant United States 17 578 1.3× 247 0.6× 269 1.8× 70 0.9× 76 1.1× 26 1.0k
Michael R. Angelastro United States 13 353 0.8× 306 0.8× 79 0.5× 69 0.9× 110 1.5× 23 677
Daniel P. Getman United States 20 784 1.8× 451 1.2× 149 1.0× 83 1.1× 124 1.7× 31 1.4k
Soo S. Ko United States 20 561 1.3× 841 2.2× 126 0.9× 43 0.6× 32 0.4× 32 1.5k
Cesare Giordano Italy 18 492 1.1× 253 0.6× 110 0.8× 84 1.1× 39 0.5× 58 917
Michael Szelke United Kingdom 20 764 1.7× 237 0.6× 218 1.5× 35 0.4× 25 0.3× 62 1.3k
Fangyi Zhu United States 19 436 1.0× 317 0.8× 270 1.8× 75 1.0× 45 0.6× 42 1.0k
Joseph S. Warmus United States 19 448 1.0× 493 1.3× 113 0.8× 44 0.6× 27 0.4× 38 962

Countries citing papers authored by Steven R. Schow

Since Specialization
Citations

This map shows the geographic impact of Steven R. Schow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Schow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Schow more than expected).

Fields of papers citing papers by Steven R. Schow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Schow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Schow. The network helps show where Steven R. Schow may publish in the future.

Co-authorship network of co-authors of Steven R. Schow

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Schow. A scholar is included among the top collaborators of Steven R. Schow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Schow. Steven R. Schow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lum, Robert T., et al.. (2008). 5-Substituted isophthalamides as insulin receptor sensitizers. Bioorganic & Medicinal Chemistry Letters. 18(12). 3492–3494. 3 indexed citations
2.
Gable, Karissa, Betty A. Maddux, Cristina Peñaranda, et al.. (2006). Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Molecular Cancer Therapeutics. 5(4). 1079–1086. 55 indexed citations
3.
Cheng, Mingshan, Steven R. Schow, Vara Prasad Manchem, et al.. (2004). In vitro and in vivo prevention of HIV protease inhibitor‐induced insulin resistance by a novel small molecule insulin receptor activator. Journal of Cellular Biochemistry. 92(6). 1234–1245. 11 indexed citations
4.
Cai, Danying, Komath Damodaran, James Keck, et al.. (2004). Novel Cyclooxygenase-1 Inhibitors Discovered Using Affinity Fingerprints. Journal of Medicinal Chemistry. 47(20). 4875–4880. 17 indexed citations
5.
Herr, R. Jason, et al.. (2001). Preparation of 8-Substituted Xanthine CVT-124 Precursor by Late Stage Pyrimidine Ring Closure. The Journal of Organic Chemistry. 67(1). 188–193. 4 indexed citations
6.
Lum, Robert T., S.S. Kerwar, Stephanie Meyer, et al.. (1998). A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation. Biochemical Pharmacology. 55(9). 1391–1397. 31 indexed citations
7.
Lum, Robert T., et al.. (1998). Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides. Bioorganic & Medicinal Chemistry Letters. 8(3). 209–214. 33 indexed citations
8.
Schow, Steven R., Richard L. Mackman, Eric E. Brooks, et al.. (1997). Synthesis and activity of 2,6,9-trisubstituted purines. Bioorganic & Medicinal Chemistry Letters. 7(21). 2697–2702. 57 indexed citations
9.
Brooks, Eric E., Nathanael S. Gray, Alison Joly, et al.. (1997). CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation. Journal of Biological Chemistry. 272(46). 29207–29211. 111 indexed citations
10.
Schow, Steven R. & Alison Joly. (1997). N-Acetyl-leucinyl-leucinyl-norleucinal Inhibits Lipopolysaccharide-Induced NF-κB Activation and Prevents TNF and IL-6 Synthesisin Vivo. Cellular Immunology. 175(2). 199–202. 38 indexed citations
11.
Pickett, W C, et al.. (1995). A Fluorescence Assay for Geranylgeranyl Transferase Type I. Analytical Biochemistry. 225(1). 60–63. 24 indexed citations
12.
Schow, Steven R., Susan Quinn DeJoy, Michael M. Wick, & S.S. Kerwar. (1994). Diastereoselective Synthesis of the Antibiotic L-Azatyrosine. The Journal of Organic Chemistry. 59(22). 6850–6852. 13 indexed citations
13.
Schow, Steven R., et al.. (1994). An asymmetric synthesis of differentially protected meso-2,6-diaminopimelic acid. Tetrahedron Letters. 35(38). 7005–7008. 26 indexed citations
14.
Jirousek, Michael R., et al.. (1993). A synthesis or indolizidines related to castanospermine and swainsonine.. Tetrahedron Letters. 34(23). 3671–3674. 6 indexed citations
15.
Babine, Robert E., Nan Zhang, Steven R. Schow, et al.. (1992). The use of HIV-1 protease structure in inhibitor design. Bioorganic & Medicinal Chemistry Letters. 2(6). 541–546. 25 indexed citations
16.
Schow, Steven R., Jonathan D. Bloom, Andrew S. Thompson, Kevin N. Winzenberg, & Amos B. Smith. (1986). Milbemycin-avermectin studies. 5. Total synthesis of milbemycin .beta.3 and its C(12) epimer. Journal of the American Chemical Society. 108(10). 2662–2674. 66 indexed citations
17.
Stevens, Robert V., et al.. (1983). Studies on the synthesis of vitamin B-12. 3. Journal of the American Chemical Society. 105(26). 7719–7729. 19 indexed citations
18.
McMorris, Trevor C., et al.. (1983). Synthesis of dehydrooogoniol, a female-activating hormone of Achlya. The Journal of Organic Chemistry. 48(19). 3370–3372. 16 indexed citations
19.
Schow, Steven R. & Trevor C. McMorris. (1979). Utility of the Wittig reaction for the construction of side chains of steroids starting from pregnenolone. The Journal of Organic Chemistry. 44(22). 3760–3765. 48 indexed citations
20.
McMorris, Trevor C., et al.. (1978). Evidence for a C-29 hydroxyl group in oogoniol from 13C NMR spectra of model 3β,26- and 3β, 29-dihydroxy stigmast-5-enes.. Tetrahedron Letters. 19(4). 335–338. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randall W. Hungate Breakdown of academic impact, for papers by Gool F. Patel Breakdown of academic impact, for papers by Stephan K. Grant Breakdown of academic impact, for papers by Michael R. Angelastro Breakdown of academic impact, for papers by Daniel P. Getman Breakdown of academic impact, for papers by Soo S. Ko Breakdown of academic impact, for papers by Cesare Giordano Breakdown of academic impact, for papers by Michael Szelke Breakdown of academic impact, for papers by Fangyi Zhu Breakdown of academic impact, for papers by Joseph S. Warmus
Rankless by CCL
2026